Chronic Myeloid Leukemia (cml) - Neonatal Disorders

Relevant Publications

Successful Therapeutic Leukapheresis for Chronic Myeloid Leukemia Identified by Persistent Erection: A Case Report.

Issue Release: 2024

Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.

Issue Release: 2024

Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population.

Issue Release: 2024

CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.

Issue Release: 2024

Global burden and trends of leukemia attributable to high body mass index risk in adults over the past 30 years.

Issue Release: 2024

Advancements and Future Prospects in Molecular Targeted and siRNA Therapies for Chronic Myeloid Leukemia.

Issue Release: 2024

Inhibition of Tumoral VISTA to Overcome TKI Resistance via Downregulation of the AKT/mTOR and JAK2/STAT5 Pathways in CML.

Issue Release: 2024

Cases of Patients Treated in Countries With Limited Resources and Discussed by Experts of the International CML Foundation (iCMLf)-Case No. 1: A Boy Presenting With Priapism and Loss of Vision.

Issue Release: 2024

BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph leukemias?

Issue Release: 2024

Extramedullary T-lymphoblastic blast crisis in a young male with chronic myeloid leukemia: A rare presentation diagnosed on cytology and flow cytometric immunophenotyping.

Issue Release: 2024

[IMATINIB INDUCED EDEMA].

Issue Release: 2024

Challenges in management of older patients with chronic myeloid leukemia.

Issue Release: 2024

Not just for lymphoid cells: The role of the noncanonical NF-κB signaling pathway in early and late myelopoiesis with a focus on hypereosinophilic disorders.

Issue Release: 2024

Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia.

Issue Release: 2024

New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs.

Issue Release: 2024

Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant CML cells.

Issue Release: 2024

Myocardial Infarction in Chronic Myeloid Leukemia: Results from Nationwide Readmission Database.

Issue Release: 2024

Efficacy and safety of flumatinib in the treatment of newly diagnosed chronic myeloid leukemia in the chronic phase: A real-world single-center retrospective study, with a focus on premature drug discontinuation.

Issue Release: 2024

Platelet microparticles influence gene expression and modulate biological activities of chronic myeloid leukemia cells (K562).

Issue Release: 2024

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia.

Issue Release: 2024

What Can Be Done to Protect Pediatric Health in Unstable Regions?

Can Volvulus be Prevented?

How to Report Child Abuse?

How Should Parents Prepare Their Child?

How to Discuss Confidentiality with Pediatric Patients and Their Families?

Why is Antibiotic Resistance a Concern?

How Do They Address Mental Health?

When to Contact a Pediatrician?

What is the Prognosis for Children with Hyperandrogenism?

How Do Newborns Acquire Antibodies?

Chronic Myeloid Leukemia (cml) - Neonatal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics